Products

Finished Dosage Forms

  • CEFACLOR CAPSULES: 250 mg | 500 mg
  • CEFACLOR MODIFIED RELEASE TABLETS: 375 mg | 500 mg | 750 mg
  • CEFACLOR ORAL SUSPENSION: 125 mg/5 ml | 187 mg/5 ml | 250 mg/5 ml | 375 mg/5 ml
  • CEFACLOR TABLETS: 250 mg | 500 mg
  • CEFADROXIL CAPSULES: 250 mg | 500 mg
  • CEFADROXIL ORAL SUSPENSION: 250 mg/5 ml | 500 mg/5 ml
  • CEFADROXIL TABLETS: 1 g
  • CEFIXIME CAPSULES: 400 mg
  • CEFIXIME COATED TABLETS: 400 mg
  • CEFIXIME DISPERSIBLE TABLETS: 400 mg
  • CEFIXIME ORAL SUSPENSION: 100 mg/5 ml
  • CEFPROZIL CAPSULES: 250 mg | 500 mg
  • CEFPROZIL ORAL SUSPENSION: 125 mg/5 ml
  • CEFRADINE CAPSULES: 250 mg | 500 mg
  • CEFTIBUTEN CAPSULES: 400 mg
  • CEFTIBUTEN ORAL SUSPENSION: 180 mg
  • CEPHALEXIN CAPSULES: 250 mg | 500 mg
  • CEPHALEXIN ORAL SUSPENSION: 125 mg/5 ml | 250 mg/5 ml
  • CEPHALEXIN TABLETS: 250 mg | 500 mg | 1 g
  • SULOPENEM TABLETS (on exclusive basis): 500 mg

 

The patent position in the concerned country should be verified by the customer and offer is subject to final confirmation.

  • AMPICILLIN AND SULBACTAM FOR INJECTION: 1,5 g/vial | 3 g/vial | 15 g/vial
  • AMPICILLIN FOR INJECTION: 500 mg/vial | 1 g/vial | 2 g/vial | 10 g/vial 
  • CEFAZOLIN FOR INJECTION: 500 mg/vial | 1 g/vial | 2 g/vial | 10 g/vial | 20 g/vial
  • CEFEPIME FOR INJECTION: 1 g/vial | 2 g/vial
  • CEFOTAXIME FOR INJECTION: 250 mg/vial | 500 g/vial | 1 g/vial | 2 g/vial
  • CEFOXITIN FOR INJECTION: 1 g/vial | 2 g/vial | 10 g/vial
  • CEFTAROLINE FOR INJECTION (on exclusive basis): 400 mg e 600 mg
  • CEFTAZIDIME: 6g
  • CEFTAZIDIME+AVIBACTAM (on exclusive basis): 2g + 500mg (unique dosage)
  • CEFTAZIDIME FOR INJECTION: 500 mg/vial | 1 g/vial | 2 g/vial | 6 g/vial
  • CEFTRIAXONE FOR INJECTION: 250 mg/vial | 500 mg/vial | 1 g/vial | 2 g/vial | 10 g/vial
  • CEFUROXIME FOR INJECTION: 250 mg/vial | 750 mg/vial | 1,5 g/vial | 7,5 g/vial
  • CEPHALOTIN FOR INJECTION: 1 g/vial | 2 g/vial
  • CLINDAMYCIN FOR INJECTION: 300 mg/2 ml | 600 mg/4 ml
  • CLOXACILLIN FOR INJECTION: 1 g/vial | 2 g/vial
  • ERTAPENEM FOR INJECTION: 1 g/vial
  • IMIPENEM AND CILASTATIN FOR INJECTION: 250+250 mg/vial | 500+500 mg/vial
  • MEROPENEM FOR INJECTION: 500 mg/vial | 1 g/vial | 2 g/vial
  • PENICILLIN FOR INJECTION: 5 milion u/vial | 20 milion u/vial
  • PIPERACILLIN FOR INJECTION: 1 g/vial | 2 g/vial | 3 g/vial | 4 g/vial
  • PIPERACILLIN – TAZOBACTAM: 4,5 g

 

The patent position in the concerned country should be verified by the customer and offer is subject to final confirmation.

  • CEFAZOLIN FOR INJIECTION: 100 g e 300 g
  • CEFUROXIME FOR INJECTION: 75 g e 225 g
  • CEFEPIME FOR INJECTION: 100 g
  • CEFTRIAXONE FOR INJECTION: 100 g
  • CEFOXITIN FOR INJECTION: 100 g
  • VANCOMYCIN FOR INJECTION: 100 g

 

System benefits

  • Dramatically reduces potential for medication errors
  • Traceability
  • No glass means no breakage
  • Complete safety for the operators
  • Few operative steps
  • Reduction of contamination risks
  • A totally closed system
  • Maximum sterility
  • Less material wastage
  • Cost reduction
  • TEICOPLANINE 200mg | 400mg